T cell ther­a­py play­er Lyell pre­pares to open $65M man­u­fac­tur­ing fa­cil­i­ty in the Seat­tle area

When Stephen Hill was liv­ing in Puer­to Ri­co and Mary­land, over­see­ing the drug man­u­fac­tur­ing arms for Am­gen and As­traZeneca, each pho­to his fam­i­ly post­ed on Face­book made him miss his home state of Wash­ing­ton a lit­tle bit more. His dad stand­ing in a riv­er, hold­ing a fresh­ly caught steel­head trout. Oth­ers mak­ing fresh ap­ple cider at his grand­fa­ther’s farm.

But to­day, Hill’s back home, over­see­ing the open­ing of Lyell Im­munophar­ma’s new $65 mil­lion man­u­fac­tur­ing cen­ter as the firm’s chief tech­ni­cal op­er­a­tions of­fi­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER